Cryo-Cell International, Inc. (CCEL)
USD 5.52
(-2.39%)
USD 5.52
(-2.39%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -12.3 Million USD | -405.73% |
| 2022 | 4.02 Million USD | 0.53% |
| 2021 | 4 Million USD | -47.75% |
| 2020 | 7.66 Million USD | 51.33% |
| 2019 | 5.06 Million USD | -2.44% |
| 2018 | 5.18 Million USD | 3.66% |
| 2017 | 5 Million USD | 1054.59% |
| 2016 | 433.59 Thousand USD | -85.22% |
| 2015 | 2.93 Million USD | 48.05% |
| 2014 | 1.98 Million USD | 16.35% |
| 2013 | 1.7 Million USD | 199.51% |
| 2012 | -1.71 Million USD | -518.31% |
| 2011 | -276.74 Thousand USD | -108.59% |
| 2010 | 3.22 Million USD | 92.69% |
| 2009 | 1.67 Million USD | 611.79% |
| 2008 | -326.74 Thousand USD | 93.01% |
| 2007 | -4.67 Million USD | -57.86% |
| 2006 | -2.96 Million USD | -341.84% |
| 2005 | 1.22 Million USD | -61.51% |
| 2004 | 3.17 Million USD | 142.27% |
| 2003 | -7.52 Million USD | -35.86% |
| 2002 | -5.53 Million USD | -1039.57% |
| 2001 | -485.88 Thousand USD | 77.52% |
| 2000 | -2.16 Million USD | -116.11% |
| 1999 | -1 Million USD | 58.33% |
| 1998 | -2.4 Million USD | -41.18% |
| 1997 | -1.7 Million USD | -312.5% |
| 1996 | 800 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 821.22 Thousand USD | 105.08% |
| 2024 Q2 | 1.39 Million USD | 69.44% |
| 2024 Q3 | 1.38 Million USD | -0.12% |
| 2023 Q2 | 1.02 Million USD | -38.93% |
| 2023 Q1 | 1.68 Million USD | 189.37% |
| 2023 Q4 | -16.17 Million USD | -1493.24% |
| 2023 FY | -12.3 Million USD | -405.73% |
| 2023 Q3 | 1.16 Million USD | 12.95% |
| 2022 Q3 | 1.36 Million USD | 14.49% |
| 2022 FY | 4.02 Million USD | 0.53% |
| 2022 Q1 | 1.47 Million USD | 278.55% |
| 2022 Q2 | 1.19 Million USD | -18.77% |
| 2022 Q4 | 581.67 Thousand USD | -57.46% |
| 2021 Q1 | 1.23 Million USD | -43.34% |
| 2021 Q4 | -823.54 Thousand USD | -151.59% |
| 2021 Q2 | 1.99 Million USD | 61.51% |
| 2021 FY | 4 Million USD | -47.75% |
| 2021 Q3 | 1.59 Million USD | -19.99% |
| 2020 Q4 | 2.18 Million USD | -12.1% |
| 2020 Q2 | 1.75 Million USD | 40.28% |
| 2020 Q1 | 1.24 Million USD | -27.35% |
| 2020 FY | 7.66 Million USD | 51.33% |
| 2020 Q3 | 2.48 Million USD | 41.55% |
| 2019 Q4 | 1.71 Million USD | -13.73% |
| 2019 Q2 | 496.56 Thousand USD | -41.83% |
| 2019 Q3 | 1.99 Million USD | 301.37% |
| 2019 Q1 | 853.66 Thousand USD | -59.97% |
| 2019 FY | 5.06 Million USD | -2.44% |
| 2018 Q3 | 920.12 Thousand USD | -19.97% |
| 2018 FY | 5.18 Million USD | 3.66% |
| 2018 Q4 | 2.13 Million USD | 131.74% |
| 2018 Q2 | 1.14 Million USD | 16.47% |
| 2018 Q1 | 987.13 Thousand USD | -20.75% |
| 2017 FY | 5 Million USD | 1054.59% |
| 2017 Q2 | 1.19 Million USD | 6.82% |
| 2017 Q3 | 1.45 Million USD | 21.81% |
| 2017 Q4 | 1.24 Million USD | -14.23% |
| 2017 Q1 | 1.11 Million USD | 144.3% |
| 2016 Q1 | 156.42 Thousand USD | -64.58% |
| 2016 Q3 | -1.06 Million USD | -220.36% |
| 2016 Q2 | 882.38 Thousand USD | 464.1% |
| 2016 Q4 | 456.86 Thousand USD | 143.02% |
| 2016 FY | 433.59 Thousand USD | -85.22% |
| 2015 Q1 | 625.19 Thousand USD | 237.17% |
| 2015 Q2 | 602.09 Thousand USD | -3.69% |
| 2015 Q3 | 1.26 Million USD | 109.99% |
| 2015 FY | 2.93 Million USD | 48.05% |
| 2015 Q4 | 441.62 Thousand USD | -65.07% |
| 2014 FY | 1.98 Million USD | 16.35% |
| 2014 Q3 | 428.95 Thousand USD | -23.72% |
| 2014 Q4 | 185.42 Thousand USD | -56.77% |
| 2014 Q2 | 562.33 Thousand USD | -30.1% |
| 2014 Q1 | 804.52 Thousand USD | 71.77% |
| 2013 FY | 1.7 Million USD | 199.51% |
| 2013 Q1 | 563.06 Thousand USD | 202.77% |
| 2013 Q2 | 88.82 Thousand USD | -84.22% |
| 2013 Q3 | 582.53 Thousand USD | 555.8% |
| 2013 Q4 | 468.36 Thousand USD | -19.6% |
| 2012 Q1 | -79.94 Thousand USD | -125.78% |
| 2012 FY | -1.71 Million USD | -518.31% |
| 2012 Q4 | -547.9 Thousand USD | -1525.23% |
| 2012 Q3 | 38.44 Thousand USD | 103.43% |
| 2012 Q2 | -1.12 Million USD | -1303.12% |
| 2011 Q1 | 685.75 Thousand USD | -6.28% |
| 2011 Q3 | -1.9 Million USD | -401.94% |
| 2011 FY | -276.74 Thousand USD | -108.59% |
| 2011 Q4 | 310.13 Thousand USD | 116.3% |
| 2011 Q2 | 630.21 Thousand USD | -8.1% |
| 2010 Q2 | 788.85 Thousand USD | 13.11% |
| 2010 Q3 | 1 Million USD | 27.31% |
| 2010 Q1 | 697.42 Thousand USD | 811.18% |
| 2010 Q4 | 731.71 Thousand USD | -27.14% |
| 2010 FY | 3.22 Million USD | 92.69% |
| 2009 Q3 | 514.31 Thousand USD | -28.76% |
| 2009 Q1 | 534.08 Thousand USD | 251.8% |
| 2009 Q2 | 721.92 Thousand USD | 35.17% |
| 2009 Q4 | -98.06 Thousand USD | -119.07% |
| 2009 FY | 1.67 Million USD | 611.79% |
| 2008 Q4 | 151.81 Thousand USD | 279.69% |
| 2008 Q1 | -160.72 Thousand USD | 88.01% |
| 2008 Q2 | -288.41 Thousand USD | -79.45% |
| 2008 Q3 | -84.49 Thousand USD | 70.71% |
| 2008 FY | -326.74 Thousand USD | 93.01% |
| 2007 Q4 | -1.34 Million USD | -32.46% |
| 2007 FY | -4.67 Million USD | -57.86% |
| 2007 Q1 | -866.27 Thousand USD | 15.59% |
| 2007 Q2 | -1.45 Million USD | -67.81% |
| 2007 Q3 | -1.01 Million USD | 30.38% |
| 2006 Q3 | -1.04 Million USD | -33.78% |
| 2006 Q4 | -1.02 Million USD | 1.58% |
| 2006 Q2 | -779.41 Thousand USD | -597.9% |
| 2006 Q1 | -111.68 Thousand USD | -120.23% |
| 2006 FY | -2.96 Million USD | -341.84% |
| 2005 Q1 | 266.99 Thousand USD | 91.33% |
| 2005 Q2 | -268.47 Thousand USD | -200.55% |
| 2005 Q4 | 551.95 Thousand USD | -18.04% |
| 2005 Q3 | 673.48 Thousand USD | 350.85% |
| 2005 FY | 1.22 Million USD | -61.51% |
| 2004 Q3 | 2.02 Million USD | 172.98% |
| 2004 Q1 | 272.44 Thousand USD | 105.63% |
| 2004 Q4 | 139.55 Thousand USD | -93.12% |
| 2004 Q2 | 742.77 Thousand USD | 172.64% |
| 2004 FY | 3.17 Million USD | 142.27% |
| 2003 Q3 | -745.61 Thousand USD | 26.97% |
| 2003 FY | -7.52 Million USD | -35.86% |
| 2003 Q1 | -919.59 Thousand USD | 75.26% |
| 2003 Q4 | -4.83 Million USD | -548.66% |
| 2003 Q2 | -1.02 Million USD | -11.03% |
| 2002 Q3 | -1.32 Million USD | -272.58% |
| 2002 Q1 | -137.38 Thousand USD | 70.17% |
| 2002 Q2 | -355.99 Thousand USD | -159.13% |
| 2002 FY | -5.53 Million USD | -1039.57% |
| 2002 Q4 | -3.71 Million USD | -180.27% |
| 2001 Q4 | -460.49 Thousand USD | -468.99% |
| 2001 Q3 | -80.93 Thousand USD | -117.85% |
| 2001 Q2 | 453.46 Thousand USD | 213.96% |
| 2001 Q1 | -397.92 Thousand USD | 41.3% |
| 2001 FY | -485.88 Thousand USD | 77.52% |
| 2000 FY | -2.16 Million USD | -116.11% |
| 2000 Q4 | -677.9 Thousand USD | -19.95% |
| 2000 Q3 | -565.16 Thousand USD | -20.91% |
| 2000 Q2 | -467.42 Thousand USD | -27.42% |
| 2000 Q1 | -366.84 Thousand USD | -152.41% |
| 1999 Q2 | -400 Thousand USD | 0.0% |
| 1999 Q1 | -400 Thousand USD | 50.0% |
| 1999 Q4 | 700 Thousand USD | 187.5% |
| 1999 Q3 | -800 Thousand USD | -100.0% |
| 1999 FY | -1 Million USD | 58.33% |
| 1998 Q2 | -500 Thousand USD | -66.67% |
| 1998 FY | -2.4 Million USD | -41.18% |
| 1998 Q4 | -800 Thousand USD | -60.0% |
| 1998 Q3 | -500 Thousand USD | 0.0% |
| 1998 Q1 | -300 Thousand USD | 62.5% |
| 1997 Q4 | -800 Thousand USD | -166.67% |
| 1997 Q1 | -100 Thousand USD | 92.31% |
| 1997 Q2 | -300 Thousand USD | -200.0% |
| 1997 FY | -1.7 Million USD | -312.5% |
| 1997 Q3 | -300 Thousand USD | 0.0% |
| 1996 Q2 | 700 Thousand USD | 0.0% |
| 1996 Q3 | 700 Thousand USD | 0.0% |
| 1996 Q4 | -1.3 Million USD | -285.71% |
| 1996 FY | 800 Thousand USD | 0.0% |
| 1996 Q1 | 700 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 102.429% |
| Addus HomeCare Corporation | 90.95 Million USD | 113.527% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | 229.748% |
| Amedisys, Inc. | 156.39 Million USD | 107.867% |
| American Oncology Network, Inc. | -49.15 Million USD | 74.968% |
| Astrana Health, Inc. | 84.61 Million USD | 114.542% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | 252.429% |
| IMAC Holdings, Inc. | -6.37 Million USD | -92.989% |
| biote Corp. | 28.65 Million USD | 142.936% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | 110.916% |
| COMPASS Pathways plc | -136.91 Million USD | 91.014% |
| DocGo Inc. | 15.05 Million USD | 181.727% |
| The Ensign Group, Inc. | 255.36 Million USD | 104.818% |
| Healthcare Services Group, Inc. | 62.35 Million USD | 119.731% |
| InnovAge Holding Corp. | -23.18 Million USD | 46.92% |
| Assure Holdings Corp. | -20.08 Million USD | 38.731% |
| The Joint Corp. | -2.07 Million USD | -493.513% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 93.495% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 21.649% |
| ModivCare Inc. | -139.94 Million USD | 91.208% |
| NewGenIvf Group Limited | 42.24 Thousand USD | 29227.484% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | -43.854% |
| Option Care Health, Inc. | 314.59 Million USD | 103.911% |
| P3 Health Partners Inc. | -167.86 Million USD | 92.67% |
| P3 Health Partners Inc. | -167.86 Million USD | 92.67% |
| The Pennant Group, Inc. | 25.16 Million USD | 148.886% |
| Surgery Partners, Inc. | 328 Million USD | 103.751% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | -326.099% |
| Talkspace, Inc. | -23.2 Million USD | 46.986% |
| Talkspace, Inc. | -23.2 Million USD | 46.986% |
| The Oncology Institute, Inc. | -77.01 Million USD | 84.024% |
| The Oncology Institute, Inc. | -77.01 Million USD | 84.024% |